← 전체 보충제 목록

엽산 (합성)

Vitamin B9 (Folic Acid)

📑 PubMed 30편 💊 비타민

📚 관련 논문 (30편)

1.
Spina bifida in Africa: A systematic review and Meta-Analysis of Presentation, Management, and outcomes.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2026 PMID:41849992

1. J Clin Neurosci. 2026 Jun;148:111986. doi: 10.1016/j.jocn.2026.111986. Epub 2026 Mar 17. Spina bifida in Africa: A systematic review and Meta-Analysis of Presentation, Management, and outcomes. O'Leary S(1), Newsome-Cuby T(2), Odiase P(3), Patel S(4), Khalil ME(5), Pulido S(6), Gowda P(7), Y

2.
Prevalence of Congenital Abnormalities in Abortuses and Stillbirths in India: A Systematic Review and Meta-Analysis.
Congenital anomalies 2026 PMID:41833543

2. Congenit Anom (Kyoto). 2026 Jan-Dec;66(1):e70050. doi: 10.1002/cga.70050. Prevalence of Congenital Abnormalities in Abortuses and Stillbirths in India: A Systematic Review and Meta-Analysis. Das SS(1), Sharma S(1), Mahajan R(1), Kaushal S(2), Sharma M(3), Singh H(1), Ramkumar M(1). Author in

3.
Complex Effects of B-Vitamin Combinations on Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials over Three Decades.
Nutrients 2026 PMID:41830012

3. Nutrients. 2026 Mar 5;18(5):842. doi: 10.3390/nu18050842. Complex Effects of B-Vitamin Combinations on Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials over Three Decades. Ren R(1), Yang A(2), Chow A(3), Wang K(4), Wang S(5), Leo C(6), Lu Y(7)(8),

4.
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
The Cochrane database of systematic reviews 2026 PMID:41705996

4. Cochrane Database Syst Rev. 2026 Feb 18;2(2):CD014217. doi: 10.1002/14651858.CD014217.pub2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Qi YP(1), Crider KS(1), Gutman J(2), Centeno-Tablante E(3)(4), Fot

5.
The effect of prenatal balanced energy and protein supplementation on small vulnerable newborn types in low- and middle-income countries: A systematic review and meta-analysis of individual participant data.
PLoS medicine 2026 PMID:41701774

5. PLoS Med. 2026 Feb 17;23(2):e1004716. doi: 10.1371/journal.pmed.1004716. eCollection 2026 Feb. The effect of prenatal balanced energy and protein supplementation on small vulnerable newborn types in low- and middle-income countries: A systematic review and meta-analysis of individual particip

6.
Influencing factors of neural tube malformation: a systematic review and meta-analysis.
African health sciences 2025 PMID:41640554

6. Afr Health Sci. 2025 Mar;25(1):604-622. doi: 10.4314/ahs.v25i1.45. Influencing factors of neural tube malformation: a systematic review and meta-analysis. Wu X(1), Bian X(1), Zheng Q(1), Gu Y(1), Wang Y(1), Bao T(1), Zhou W(1). Author information: (1)Department 2 of Ultrasonography, Baoding N

7.
Combined B-vitamin supplementation on homocysteine and vascular outcomes in coronary heart disease: a meta-analysis.
Annals of medicine 2026 PMID:41615824

7. Ann Med. 2026 Dec;58(1):2622208. doi: 10.1080/07853890.2026.2622208. Epub 2026 Jan 30. Combined B-vitamin supplementation on homocysteine and vascular outcomes in coronary heart disease: a meta-analysis. Guo L(1), Shi X(2), Wang G(3), Han W(1), Ding R(1), Wang S(4), Yuan D(3). Author informa

8.
Oral iron supplements for children in malaria-endemic areas.
The Cochrane database of systematic reviews 2026 PMID:41510785

8. Cochrane Database Syst Rev. 2026 Jan 9;1(1):CD006589. doi: 10.1002/14651858.CD006589.pub5. Oral iron supplements for children in malaria-endemic areas. Itzkovich M(1)(2), Neuberger A(3), Harris I(4)(5), Yahav D(1)(5), Paul M(3), Gilboa M(5)(6). Author information: (1)Infectious Diseases Unit

9.
Folate Intake and Breast Cancer Risk: A Systematic Review and Meta-Analysis.
Molecular nutrition & food research 2026 PMID:41437765

9. Mol Nutr Food Res. 2026 Jan;70(1):e70354. doi: 10.1002/mnfr.70354. Folate Intake and Breast Cancer Risk: A Systematic Review and Meta-Analysis. Eleotério MR(1), Ferreira LS(1), Azevedo FM(1), Candido AC(1), Franceschini SDCC(1), de Souza ECG(1). Author information: (1)Department of Nutrition

10.
The effectiveness and safety of the active form of folate on biochemical parameters in women of childbearing age: A systematic review and meta-analysis.
Medicine 2025 PMID:41398893

10. Medicine (Baltimore). 2025 Dec 12;104(50):e46564. doi: 10.1097/MD.0000000000046564. The effectiveness and safety of the active form of folate on biochemical parameters in women of childbearing age: A systematic review and meta-analysis. Xie M(1)(2)(3)(4), Qing X(1), Huang H(1), Zhang J(2)(3)

11.
A prospective, randomized, double-blind, placebo-controlled, multicenter study of thiamin plus folic acid in the treatment of cognitive impairment in patients undergoing maintenance hemodialysis.
Renal failure 2026 PMID:42059045

11. Ren Fail. 2026 Dec;48(1):2658981. doi: 10.1080/0886022X.2026.2658981. Epub 2026 Apr 30. A prospective, randomized, double-blind, placebo-controlled, multicenter study of thiamin plus folic acid in the treatment of cognitive impairment in patients undergoing maintenance hemodialysis. Xie K(1

12.
[Preliminary analysis of mFOLFOXIRI plus bevacizumab combined with cytoreductive surgery for resectable peritoneal metastases from colorectal cancer: a prospective,randomized phase II clinical trial].
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2026 PMID:42045712

12. Zhonghua Wei Chang Wai Ke Za Zhi. 2026 Apr 25;29(4):484-491. doi: 10.3760/cma.j.cn441530-20260110-00026. [Preliminary analysis of mFOLFOXIRI plus bevacizumab combined with cytoreductive surgery for resectable peritoneal metastases from colorectal cancer: a prospective,randomized phase II cli

13.
STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancer.
Signal transduction and targeted therapy 2026 PMID:41980919

13. Signal Transduct Target Ther. 2026 Apr 14;11(1):133. doi: 10.1038/s41392-026-02639-y. STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancer. Chibaudel B(1), Dourthe LM(2), André T(3), Henriques J(4

14.
Determination of Folate Bioavailability From Brewer's Yeast in a Dual Isotope Randomized Human Intervention Study.
Molecular nutrition & food research 2026 PMID:41954190

14. Mol Nutr Food Res. 2026 Apr;70(7):e70453. doi: 10.1002/mnfr.70453. Determination of Folate Bioavailability From Brewer's Yeast in a Dual Isotope Randomized Human Intervention Study. Weber N(1), Striegel L(1), Methner Y(2), Brandl B(3), Groehn V(4), Knapp JP(4), Skurk T(3)(5), Rychlik M(1)(6)

15.
Perception and acceptance of micronutrient-Fortified Bouillon among Non-Index Household Members: A longitudinal sub-study nested within a randomized trial in Northern Ghana.
PloS one 2026 PMID:41931601

15. PLoS One. 2026 Apr 3;21(4):e0345106. doi: 10.1371/journal.pone.0345106. eCollection 2026. Perception and acceptance of micronutrient-Fortified Bouillon among Non-Index Household Members: A longitudinal sub-study nested within a randomized trial in Northern Ghana. Kyereh FK(1), Ohemeng AN(1)

16.
Second-line liposomal irinotecan plus S-1 vs. liposomal irinotecan plus 5-fluorouracil in metastatic pancreatic cancer: The phase I/II randomized NAPAN trial.
European journal of cancer (Oxford, England : 1990) 2026 PMID:41921365

18. Eur J Cancer. 2026 May 15;239:116683. doi: 10.1016/j.ejca.2026.116683. Epub 2026 Mar 20. Second-line liposomal irinotecan plus S-1 vs. liposomal irinotecan plus 5-fluorouracil in metastatic pancreatic cancer: The phase I/II randomized NAPAN trial. Gehrels AM(1), Pijnappel EN(2), van Daalen

17.
Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical Trial.
JAMA network open 2026 PMID:41915391

30. JAMA Netw Open. 2026 Mar 2;9(3):e263861. doi: 10.1001/jamanetworkopen.2026.3861. Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical Trial. Seelen LWF(1)(2), Brada LJH(1)(2), Walma MS(1)(2), Rombouts SJE(1)(2), B

18.
Aflibercept and 5-FU vs. FOLFOX as 1st line treatment for older adults or frail elderly patients with metastatic colorectal cancer - The randomized phase 2 AIO / IKF ELDERLY trial (AIO-KRK-0117 / IKF 629).
European journal of cancer (Oxford, England : 1990) 2026 PMID:41905242

35. Eur J Cancer. 2026 May 15;239:116689. doi: 10.1016/j.ejca.2026.116689. Epub 2026 Mar 24. Aflibercept and 5-FU vs. FOLFOX as 1st line treatment for older adults or frail elderly patients with metastatic colorectal cancer - The randomized phase 2 AIO / IKF ELDERLY trial (AIO-KRK-0117 / IKF 629

19.
Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST).
European journal of cancer (Oxford, England : 1990) 2026 PMID:41880871

41. Eur J Cancer. 2026 May 2;238:116688. doi: 10.1016/j.ejca.2026.116688. Epub 2026 Mar 19. Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST). Kito Y(1), Yamazaki K(2), Shoji H(3),

20.
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer.
The New England journal of medicine 2026 PMID:41880612

28. N Engl J Med. 2026 Mar 26;394(12):1155-1166. doi: 10.1056/NEJMoa2507874. Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer. Sinicrope FA(1)(2), Ou FS(3), Arnold D(4), Peters WR(5), Behrens RJ(6), Lieu CH(7), Matin K(8), Cohen DJ(9), Potter SL(10), Nixon AB(11), Kot

21.
Tumor-targeted Exosomal Delivery of Celastrol for Enhanced Therapeutic Efficacy in NSCLC.
Theranostics 2026 PMID:41993621

8. Theranostics. 2026 Mar 3;16(10):5125-5149. doi: 10.7150/thno.125096. eCollection 2026. Tumor-targeted Exosomal Delivery of Celastrol for Enhanced Therapeutic Efficacy in NSCLC. Moholkar DN(1)(2), Kandimalla R(1)(2), Saeed M(3), Arif Y(1), Tyagi N(1), Singhal R(4)(5), Kyakulaga AH(1)(2), Saee

22.
JI-CJ002, a Natural Herbal Formula, Enhances the Antitumor Efficacy of FOLFOX in Colorectal Cancer by Suppressing the DDR Pathway.
Anticancer research 2025 PMID:41151903

19. Anticancer Res. 2025 Nov;45(11):4987-5000. doi: 10.21873/anticanres.17841. JI-CJ002, a Natural Herbal Formula, Enhances the Antitumor Efficacy of FOLFOX in Colorectal Cancer by Suppressing the DDR Pathway. Kim MW(#)(1), Kim D(#)(1), Lee SE(1), Ahn J(1), Park B(1), Cheon C(1)(2)(3), Ko SG(4)(

23.
Synergistic alleviation of obesity and associated cardiovascular complications by combined modulation of FASN/Arginase/eNOS uncoupling.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2025 PMID:40882518

50. Biomed Pharmacother. 2025 Oct;191:118486. doi: 10.1016/j.biopha.2025.118486. Epub 2025 Aug 28. Synergistic alleviation of obesity and associated cardiovascular complications by combined modulation of FASN/Arginase/eNOS uncoupling. Sabry EA(1), Elbatreek MH(2), El-Basossy HM(3), Hassan NA(4).

24.
Contribution of Organic Anion Transporter 3 in Delayed Elimination of Methotrexate by Concomitant Administration of Febuxostat.
Biopharmaceutics & drug disposition 2025 PMID:40855615

38. Biopharm Drug Dispos. 2025 Aug;46(4):165-171. doi: 10.1002/bdd.70014. Epub 2025 Aug 25. Contribution of Organic Anion Transporter 3 in Delayed Elimination of Methotrexate by Concomitant Administration of Febuxostat. Ikemura K(1)(2), Kobayashi S(3), Wang D(2), Okuda M(1)(2). Author informati

25.
Carrier-Free Nanomedicine Based on Celastrol and Methotrexate for Synergistic Treatment of Breast Cancer via Folate Targeting.
International journal of nanomedicine 2025 PMID:40599402

18. Int J Nanomedicine. 2025 Jun 27;20:8291-8304. doi: 10.2147/IJN.S516921. eCollection 2025. Carrier-Free Nanomedicine Based on Celastrol and Methotrexate for Synergistic Treatment of Breast Cancer via Folate Targeting. Li X(1), Zhang M(1), Wang X(1), Ma P(2), Song Y(1). Author information: (1

26.
Synergetic effects of Ulva lactuca and Pterocladiella capillacea on the multidrug-resistant Klebsiella pneumoniae.
BMC microbiology 2025 PMID:40571941

32. BMC Microbiol. 2025 Jun 26;25(1):370. doi: 10.1186/s12866-025-04102-4. Synergetic effects of Ulva lactuca and Pterocladiella capillacea on the multidrug-resistant Klebsiella pneumoniae. Mahmoud RM(1), Khedr GM(2), Taha RM(2), Adawy AA(2). Author information: (1)Botany Department, Faculty of

27.
Molecular Dynamics Simulations of Plasma-Antifolate Drug Synergy in Cancer Therapy.
Biomolecules 2025 PMID:40563414

33. Biomolecules. 2025 May 27;15(6):773. doi: 10.3390/biom15060773. Molecular Dynamics Simulations of Plasma-Antifolate Drug Synergy in Cancer Therapy. Niu Y(1), Zhao T(1), Wang X(1), Sun Y(1), Zhang Y(1). Author information: (1)School of Electrical Engineering, Shandong University, Ji'nan 25006

28.
Perturbation of Pseudomonas aeruginosa peptidoglycan recycling by anti-folates and design of a dual-action inhibitor.
mBio 2025 PMID:39878530

32. mBio. 2025 Mar 12;16(3):e0298424. doi: 10.1128/mbio.02984-24. Epub 2025 Jan 29. Perturbation of Pseudomonas aeruginosa peptidoglycan recycling by anti-folates and design of a dual-action inhibitor. Yaeger LN(1)(2), Sychantha D(1)(2), Luong P(1)(2), Shekarriz S(1)(2), Goncalves O(3), Dobrin A

29.
Synergistically effects of n-3 PUFA and B vitamins prevent diabetic cognitive dysfunction through promoting TET2-mediated active DNA demethylation.
Clinical nutrition (Edinburgh, Scotland) 2025 PMID:39798222

9. Clin Nutr. 2025 Feb;45:111-123. doi: 10.1016/j.clnu.2025.01.002. Epub 2025 Jan 6. Synergistically effects of n-3 PUFA and B vitamins prevent diabetic cognitive dysfunction through promoting TET2-mediated active DNA demethylation. Chen L(1), Liu R(2), He X(3), Fang J(2), Zhou L(2), Qi Z(2), Ta

30.
Green Tea Catechins as Perpetrators of Drug Pharmacokinetic Interactions.
Clinical pharmacology and therapeutics 2025 PMID:39748104

7. Clin Pharmacol Ther. 2025 Jul;118(1):45-61. doi: 10.1002/cpt.3547. Epub 2025 Jan 2. Green Tea Catechins as Perpetrators of Drug Pharmacokinetic Interactions. Kyriacou NM(1), Gross AS(1), McLachlan AJ(1). Author information: (1)Sydney Pharmacy School, Faculty of Medicine and Health, University

⚠️ 면책 고지

이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.